In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Boston Scientific's current price at $46.76 contrasts with a high-confidence fair value of $87.39, indicating substantial upside potential. Valuation methods vary widely, but Monte Carlo analysis shows high volatility and low downside risk (12.5%), suggesting asymmetric opportunity with manageable risk. Financial health scores reflect solid liquidity and growth but moderate profitability and efficiency.